Kewaunee Scientific Corporation - Common Stock (KEQU)
Healthcare › Laboratory Apparatus & Furniture
Price History
Feb 9, 2026 — May 10, 2026Investment Snapshot
- Trading 3% below Graham Number — thin margin of safety
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 10.7% — below-average profitability
- Revenue growing at 18% annually
Kewaunee Scientific Corporation - Common Stock (KEQU) is a Healthcare company operating in Laboratory Apparatus & Furniture, listed on the NASDAQ , with a market capitalisation of $106 million . Key value metrics: P/E ratio 14.0, P/B ratio 1.50, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Kewaunee Scientific Corporation - Common Stock — Fundamental Analysis Summary
Kewaunee Scientific Corporation - Common Stock (KEQU) is trading 3% below its Graham Number of $38.31, offering a thin margin of safety. The stock carries a reasonable trailing P/E ratio of 14.0x.
On financial health, KEQU shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 10.7% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.32.
StockPik's composite Value Score for KEQU is 87/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
KEQU reports a moderate gross margin of 27.9% (sector average: 40.1%) and a modest operating margin of 4.9%.
KEQU shows revenue growing at 18% year-over-year, with earnings declining at 39%.